Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, December 05, 2015 12:04:30 PM
bullish 2.86
inverted head and shoulders
moving average breakout
## source: finance.yahoo.com
Wed, 02 Dec 2015 12:16:39 GMT ~ Curis to Present at the Oppenheimer 26th Annual Healthcare Conference
[at noodls] - LEXINGTON, Mass., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of ...
read full: http://www.noodls.com/view/C6EAFA84393814D6BB5FF56CFC717DAD5432B8E2
*********************************************************
Wed, 02 Dec 2015 12:00:00 GMT ~ Curis to Present at the Oppenheimer 26th Annual Healthcare Conference
[GlobeNewswire] - LEXINGTON, Mass. -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...
read full: http://finance.yahoo.com/news/curis-present-oppenheimer-26th-annual-120000605.html
*********************************************************
Sat, 28 Nov 2015 12:52:58 GMT ~ Is Rayonier Advanced Materials Inc (RYAM) A Good Stock To Buy?
read full: http://www.insidermonkey.com/blog/is-rayonier-advanced-materials-inc-ryam-a-good-stock-to-buy-392325/
*********************************************************
Wed, 25 Nov 2015 14:18:00 GMT ~ Technical Insight on Equity Movement - Research on Ignyta, KongZhong, Arbutus Biopharma and Curis
[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 25, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ignyta Inc ...
read full: http://finance.yahoo.com/news/technical-insight-equity-movement-research-141800255.html
*********************************************************
Wed, 18 Nov 2015 18:04:21 GMT ~ CURIS INC Financials
read full: http://finance.yahoo.com/q/is?s=cris
*********************************************************
$CRIS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CRIS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CRIS/company-info
Ticker: $CRIS
OTC Market Place: Not Available
CIK code: 0001108205
Company name: Curis, Inc.
Company website: http://www.curis.com
Incorporated In: DE, USA
$CRIS share structure
## source: otcmarkets.com
Market Value: $367,208,713 a/o Dec 04, 2015
Shares Outstanding: 128,394,655 a/o Nov 05, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$CRIS extra dd links
Company name: Curis, Inc.
Company website: http://www.curis.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CRIS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CRIS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CRIS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/news - http://finance.yahoo.com/q/h?s=CRIS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CRIS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CRIS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CRIS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Curis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Curis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Curis%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.curis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.curis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.curis.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CRIS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001108205&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CRIS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CRIS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CRIS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CRIS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CRIS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CRIS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CRIS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CRIS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CRIS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CRIS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CRIS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CRIS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CRIS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CRIS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CRIS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CRIS
$CRIS DD Notes ~ http://www.ddnotesmaker.com/CRIS
Recent CRIS News
- Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 • PR Newswire (US) • 04/30/2024 12:00:00 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 04/05/2024 11:30:00 AM
- Curis to Present at Upcoming Healthcare Conferences in April • PR Newswire (US) • 04/04/2024 11:30:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:16:14 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/08/2024 09:36:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/08/2024 09:27:47 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 09:01:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 01:01:02 PM
- Curis Provides Fourth Quarter 2023 Business Update • PR Newswire (US) • 02/08/2024 01:00:00 PM
- Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 • PR Newswire (US) • 02/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 01:13:35 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 01/05/2024 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 12/21/2023 09:00:47 PM
- Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study • PR Newswire (US) • 12/12/2023 01:00:00 PM
- Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference • PR Newswire (US) • 12/11/2023 01:00:00 PM
- Curis Announces Three Presentations at ASH • PR Newswire (US) • 12/06/2023 01:00:00 PM
- Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma • PR Newswire (US) • 12/05/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 12:03:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 12:01:51 PM
- Curis Provides Third Quarter 2023 Business Update • PR Newswire (US) • 11/02/2023 12:00:00 PM
- Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023 • PR Newswire (US) • 10/26/2023 12:30:00 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 10/06/2023 12:56:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/28/2023 08:05:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 12:54:37 PM
- Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer • PR Newswire (US) • 09/12/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM